Biomarker subset analysis of a phase IIIb, open-label study of afatinib in EGFR tyrosine kinase inhibitor-naive patients with EGFRm+ non-small-cell lung cancer

Biomarker subset analysis of a phase IIIb, open-label study of afatinib in EGFR tyrosine kinase inhibitor-naive patients with EGFRm+ non-small-cell lung cancer

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Future oncology (London, England) England), 2022-04, Vol.18 (12), p.1485-1497
Hauptverfasser: Zhao, Jun, Bai, Hua, Wang, Xin, Wang, Yuyan, Duan, Jianchun, Chen, Hanxiao, Xue, Zhiyi, Tian, Yahui, Cseh, Agnieszka, Huang, Dennis Chin-Lun, Wu, Yi-Long, Wang, Jie
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1497
container_issue 12
container_start_page 1485
container_title Future oncology (London, England)
container_volume 18
creator Zhao, Jun
Bai, Hua
Wang, Xin
Wang, Yuyan
Duan, Jianchun
Chen, Hanxiao
Xue, Zhiyi
Tian, Yahui
Cseh, Agnieszka
Huang, Dennis Chin-Lun
Wu, Yi-Long
Wang, Jie
description
doi_str_mv 10.2217/fon-2021-0394
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2626010229</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2626010229</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1424-c65b2b4c0818ca04bc80bab5f5e6fed46136a0ae5501c4e2b0e8eeeff52f115a3</originalsourceid><addsrcrecordid>eNotjsFKAzEURQdBsFaX7t9S0GiSSabTpZa2FgqC6Lq8TF9sbCYZJzNKv8Zfta2u7uacy8myK8HvpBSjexsDk1wKxvOxOskGYqQUK3MuzrLzlD44V6Nc80H28-hije2WWki9SdQBBvS75BJECwjNBhPBYrEwtxAbCsyjIQ-p69e7I2Gxc8EZcAGm89kLdLs2JhcIti4cVBc2zrgutiyg-yJo9jyFLsG36zZHpb6BsK9NNXrPKvIefB_eocJQUXuRnVr0iS7_d5i9zaavkye2fJ4vJg9L1gglFasKbaRRFS9FWSFXpiq5QaOtpsLSWhUiL5Ajac1FpUgaTiURWaulFUJjPsyu_36bNn72lLpV7dIhBgPFPq1kIQsuuJTj_BeR622l</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2626010229</pqid></control><display><type>article</type><title>Biomarker subset analysis of a phase IIIb, open-label study of afatinib in EGFR tyrosine kinase inhibitor-naive patients with EGFRm+ non-small-cell lung cancer</title><source>PubMed Central</source><creator>Zhao, Jun ; Bai, Hua ; Wang, Xin ; Wang, Yuyan ; Duan, Jianchun ; Chen, Hanxiao ; Xue, Zhiyi ; Tian, Yahui ; Cseh, Agnieszka ; Huang, Dennis Chin-Lun ; Wu, Yi-Long ; Wang, Jie</creator><creatorcontrib>Zhao, Jun ; Bai, Hua ; Wang, Xin ; Wang, Yuyan ; Duan, Jianchun ; Chen, Hanxiao ; Xue, Zhiyi ; Tian, Yahui ; Cseh, Agnieszka ; Huang, Dennis Chin-Lun ; Wu, Yi-Long ; Wang, Jie</creatorcontrib><identifier>EISSN: 1744-8301</identifier><identifier>DOI: 10.2217/fon-2021-0394</identifier><language>eng</language><ispartof>Future oncology (London, England), 2022-04, Vol.18 (12), p.1485-1497</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Zhao, Jun</creatorcontrib><creatorcontrib>Bai, Hua</creatorcontrib><creatorcontrib>Wang, Xin</creatorcontrib><creatorcontrib>Wang, Yuyan</creatorcontrib><creatorcontrib>Duan, Jianchun</creatorcontrib><creatorcontrib>Chen, Hanxiao</creatorcontrib><creatorcontrib>Xue, Zhiyi</creatorcontrib><creatorcontrib>Tian, Yahui</creatorcontrib><creatorcontrib>Cseh, Agnieszka</creatorcontrib><creatorcontrib>Huang, Dennis Chin-Lun</creatorcontrib><creatorcontrib>Wu, Yi-Long</creatorcontrib><creatorcontrib>Wang, Jie</creatorcontrib><title>Biomarker subset analysis of a phase IIIb, open-label study of afatinib in EGFR tyrosine kinase inhibitor-naive patients with EGFRm+ non-small-cell lung cancer</title><title>Future oncology (London, England)</title><issn>1744-8301</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNotjsFKAzEURQdBsFaX7t9S0GiSSabTpZa2FgqC6Lq8TF9sbCYZJzNKv8Zfta2u7uacy8myK8HvpBSjexsDk1wKxvOxOskGYqQUK3MuzrLzlD44V6Nc80H28-hije2WWki9SdQBBvS75BJECwjNBhPBYrEwtxAbCsyjIQ-p69e7I2Gxc8EZcAGm89kLdLs2JhcIti4cVBc2zrgutiyg-yJo9jyFLsG36zZHpb6BsK9NNXrPKvIefB_eocJQUXuRnVr0iS7_d5i9zaavkye2fJ4vJg9L1gglFasKbaRRFS9FWSFXpiq5QaOtpsLSWhUiL5Ajac1FpUgaTiURWaulFUJjPsyu_36bNn72lLpV7dIhBgPFPq1kIQsuuJTj_BeR622l</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Zhao, Jun</creator><creator>Bai, Hua</creator><creator>Wang, Xin</creator><creator>Wang, Yuyan</creator><creator>Duan, Jianchun</creator><creator>Chen, Hanxiao</creator><creator>Xue, Zhiyi</creator><creator>Tian, Yahui</creator><creator>Cseh, Agnieszka</creator><creator>Huang, Dennis Chin-Lun</creator><creator>Wu, Yi-Long</creator><creator>Wang, Jie</creator><scope>7X8</scope></search><sort><creationdate>20220401</creationdate><title>Biomarker subset analysis of a phase IIIb, open-label study of afatinib in EGFR tyrosine kinase inhibitor-naive patients with EGFRm+ non-small-cell lung cancer</title><author>Zhao, Jun ; Bai, Hua ; Wang, Xin ; Wang, Yuyan ; Duan, Jianchun ; Chen, Hanxiao ; Xue, Zhiyi ; Tian, Yahui ; Cseh, Agnieszka ; Huang, Dennis Chin-Lun ; Wu, Yi-Long ; Wang, Jie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1424-c65b2b4c0818ca04bc80bab5f5e6fed46136a0ae5501c4e2b0e8eeeff52f115a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhao, Jun</creatorcontrib><creatorcontrib>Bai, Hua</creatorcontrib><creatorcontrib>Wang, Xin</creatorcontrib><creatorcontrib>Wang, Yuyan</creatorcontrib><creatorcontrib>Duan, Jianchun</creatorcontrib><creatorcontrib>Chen, Hanxiao</creatorcontrib><creatorcontrib>Xue, Zhiyi</creatorcontrib><creatorcontrib>Tian, Yahui</creatorcontrib><creatorcontrib>Cseh, Agnieszka</creatorcontrib><creatorcontrib>Huang, Dennis Chin-Lun</creatorcontrib><creatorcontrib>Wu, Yi-Long</creatorcontrib><creatorcontrib>Wang, Jie</creatorcontrib><collection>MEDLINE - Academic</collection><jtitle>Future oncology (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhao, Jun</au><au>Bai, Hua</au><au>Wang, Xin</au><au>Wang, Yuyan</au><au>Duan, Jianchun</au><au>Chen, Hanxiao</au><au>Xue, Zhiyi</au><au>Tian, Yahui</au><au>Cseh, Agnieszka</au><au>Huang, Dennis Chin-Lun</au><au>Wu, Yi-Long</au><au>Wang, Jie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biomarker subset analysis of a phase IIIb, open-label study of afatinib in EGFR tyrosine kinase inhibitor-naive patients with EGFRm+ non-small-cell lung cancer</atitle><jtitle>Future oncology (London, England)</jtitle><date>2022-04-01</date><risdate>2022</risdate><volume>18</volume><issue>12</issue><spage>1485</spage><epage>1497</epage><pages>1485-1497</pages><eissn>1744-8301</eissn><doi>10.2217/fon-2021-0394</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1744-8301
ispartof Future oncology (London, England), 2022-04, Vol.18 (12), p.1485-1497
issn 1744-8301
language eng
recordid cdi_proquest_miscellaneous_2626010229
source PubMed Central
title Biomarker subset analysis of a phase IIIb, open-label study of afatinib in EGFR tyrosine kinase inhibitor-naive patients with EGFRm+ non-small-cell lung cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T18%3A48%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biomarker%20subset%20analysis%20of%20a%20phase%20IIIb,%20open-label%20study%20of%20afatinib%20in%20EGFR%20tyrosine%20kinase%20inhibitor-naive%20patients%20with%20EGFRm+%20non-small-cell%20lung%20cancer&rft.jtitle=Future%20oncology%20(London,%20England)&rft.au=Zhao,%20Jun&rft.date=2022-04-01&rft.volume=18&rft.issue=12&rft.spage=1485&rft.epage=1497&rft.pages=1485-1497&rft.eissn=1744-8301&rft_id=info:doi/10.2217/fon-2021-0394&rft_dat=%3Cproquest%3E2626010229%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2626010229&rft_id=info:pmid/&rfr_iscdi=true